The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience

Figure 2

Kaplan-Meier overall survival (OS) curve; median OS from second surgery: 14 months (95% CI 11.1–16.8 months).